Explained: which drugs has Donald Trump been prescribed and why?
Experts say cocktail of medication suggests the president may be seriously ill with Covid

The coronavirus drugs prescribed to Donald Trump indicate that the president may be battling a more severe case of Covid-19 than the White House is letting on, according to infectious disease experts.
After testing positive for coronavirus last week, Trump has been given a powerful cocktail of medications including antiviral drug remdesivir, a steroid called dexamethasone and a combination of antibodies. The 74-year-old’s doctors say he is also taking zinc, vitamin D, famotidine, melatonin and aspirin, but “it is not clear if any of these are deliberately for Covid 19”, the BBC reports.
The combination of drugs given to the president “may never have been prescribed together to an individual patient”, adds the Financial Times. Indeed, the breadth of medicines being taken by Trump has led some experts to suggest that the US leader may be more unwell than his lead physician, Sean Conley, has admitted.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some experts have raised another possibility: that Trump is directing his own treatment, and is demanding drugs that he does not fully understand.
This phenomenon, says the The New York Times, even has a name: “VIP syndrome, which describes prominent figures who receive poor medical care because doctors are too zealous in treating them - or defer too readily to their instructions”.
“You think you’re helping,” Dr Celine Gounder, a clinical assistant professor of medicine and infectious diseases at the NYU Grossman School of Medicine, told the newspaper. “But this is really a data-free zone, and you just don’t know that.”
Either way, “the use of the experimental treatments will have required a careful weighing of the risks, given the possible side-effects and the chance of adverse interactions between the different chemicals”, says the FT.
Dexamethasone
This steroid works by calming the immune system, but a British professor who led the trial of the drug has said that it works best on serious cases of Covid-19 - “adding to fears over the seriousness of the president’s illness”, The Telegraph reports.
“Dexamethasone reduces mortality or improves survival particularly for patients with severe Covid,” Martin Landray, a professor of medicine and epidemiology at the University of Oxford, told the paper.
Monoclonal antibody therapy
Made by US biotechnology company Regeneron, this combination of antibodies mimics the natural human immune response. There is “huge hope it will be effective”, says the BBC, but “the evidence in patients is still very limited and these monoclonals are still classed as an experimental drug”.
“The president is one of only a handful of people outside those trials to undergo the treatment under what is known as ‘compassionate use’,” the broadcaster adds.
Remdesivir
Developed originally as a treatment for Ebola, remdesivir works by disrupting the ability of the virus to copy itself. Clinical trials have shown the drug can cut the duration of Covid symptoms from 15 days to 11, but it is not a life-saving drug.
And the rest
Vitamin D and zinc both have a role in a healthy immune system, but have never been proven to help fight Covid.
Famotidine decreases stomach acid production and is used for people with stomach ulcers or reflux. Meanwhile, melatonin is a hormone that can improve sleep, while aspirin is a pain killer and blood thinner.
Trials to determine whether aspirin could help fight coronavirus have been launched, but no evidence supporting that hope has emerged.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
The state of Britain's Armed Forces
The Explainer Geopolitical unrest and the unreliability of the Trump administration have led to a frantic re-evaluation of the UK's military capabilities
By The Week UK
-
Anti-anxiety drug has a not-too-surprising effect on fish
Under the radar The fish act bolder and riskier
By Devika Rao, The Week US
-
Sudoku medium: April 21, 2025
The Week's daily medium sudoku puzzle
By The Week Staff
-
El Salvador's CECOT prison becomes Washington's go-to destination
IN THE SPOTLIGHT Republicans and Democrats alike are clamoring for access to the Trump administration's extrajudicial deportation camp — for very different reasons
By Rafi Schwartz, The Week US
-
Supreme Court takes up Trump birthright appeal
Speed Read The New Jersey Attorney General said a constitutional right like birthright citizenship 'cannot be turned on or off at the whims of a single man'
By Rafi Schwartz, The Week US
-
Court slams Trump, senator visits Ábrego García
Speed Read The case 'should be shocking not only to judges' but all Americans with an 'intuitive sense of liberty'
By Peter Weber, The Week US
-
The anger fueling the Bernie Sanders and Alexandria Ocasio-Cortez barnstorming tour
Talking Points The duo is drawing big anti-Trump crowds in red states
By Joel Mathis, The Week US
-
Judge threatens Trump team with criminal contempt
Speed Read James Boasberg attempts to hold the White House accountable for disregarding court orders over El Salvador deportation flights
By Rafi Schwartz, The Week US
-
Why the GOP is nervous about Ken Paxton's Senate run
Today's Big Question A MAGA-establishment battle with John Cornyn will be costly
By Joel Mathis, The Week US
-
UK-US trade deal: can Keir Starmer trust Donald Trump?
Today's Big Question White House insiders say an agreement is 'two weeks' away but can Britain believe it?
By Sorcha Bradley, The Week UK
-
A running list of Trump's second-term national security controversies
In Depth Several scandals surrounding national security have rocked the Trump administration
By Justin Klawans, The Week US